5% glucose
Sponsors
Iperboreal Pharma S.r.l., Assiut University, Meshalkin Research Institute of Pathology of Circulation, Makassed General Hospital, Weifang Medical University
Conditions
Cardiac Surgical ProceduresDizzynessEnd-Stage Kidney DiseaseHeart Valve Prosthesis ImplantationInsulin ResistanceNafamostat MesilatePainPostoperative Nausea and Vomiting
Phase 2
Phase 3
Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients
CompletedNCT02757443
Start: 2016-06-30End: 2021-05-31Updated: 2021-07-01
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR)
Active, not recruitingCTIS2024-513562-19-00
Start: 2023-04-21Target: 155Updated: 2025-05-19
Phase 4
Unknown Phase
Oral Glucose in Pain Alleviation Among Term Neonates
CompletedNCT03190980
Start: 2017-05-01End: 2018-06-30Updated: 2020-04-07
Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy
NCT05932160
Start: 2023-06-01End: 2023-12-30Target: 108Updated: 2023-11-07
Effect of Intravenous 5% Dextrose Infusion During Recovery from Anesthesia on the Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy
CompletedNCT06319144
Start: 2024-03-15End: 2024-06-22Updated: 2025-03-14